Bridgeway Capital Management, LLC Arca Biopharma, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$2.2 - $2.53 $55,000 - $63,249
25,000 Added 113.91%
46,948 $117,000
Q1 2022

May 16, 2022
BUY
$1.77 - $2.49 $38,847 - $54,650
21,948 New
21,948 $50,000

Others Institutions Holding ABIO

# of Institutions
2
Shares Held
280K
Call Options Held
0
Put Options Held
0
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email